Experimental models have shown that restoring Lrp1 function improves Aβ clearance and mitigates cognitive deficits, suggesting that Lrp1 could be a potential therapeutic target for preventing or treating neurodegenerative diseases in aging populations [1401]. The gene discussed is LRP1; the disease is Cognitive impairment.